Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Market Alert: Hinge Health's Multi-Billion Dollar Expected IPO Highlights 600% Valuation Opportunity for DarioHealth

Hinge Health’s s-1 filing seems to shed a light on DarioHealth’s potential opportunity; With Hinge targeting a potential $3-6B IPO valuation with similar growth metrics, Dario’s comparable 32.9% revenue growth, superior 80%+ gross margins, and multi-condition platform addressing the $1.2 trillion cardiometabolic disease market and $100 billion GLP-1 market create compelling value proposition; Dario currently seems to trade and significantly lower revenue multiples to Hinge’s expected IPO, creating a potential valuation arbitrage opportunity; Recent 398% B2B2C revenue surge and path to profitability by year-end strengthen Dario’s positioning amid renewed interest in the $661 billion MSK and growing digital health sector

Market News Alerts Reports: DarioHealth Corp. (Nasdaq: DRIO)* emerges as a potential hidden gem in digital health as competitor Hinge Health prepares to go public at a multi-billion-dollar valuation, highlighting a dramatic valuation gap that savvy investors are beginning to notice. With Hinge Health filing for a potential April IPO at a valuation that according to recent reports could reach $3-6 billion despite recent market volatility, DarioHealth's comprehensive AI-driven chronic care platform appears to be potentially significantly undervalued by comparison.

Financial analysis reveals striking similarities between the two digital health innovators. Hinge reported $390 million in 2024 revenue with 33% growth and 78% gross margins, while DarioHealth delivered 32.9% revenue growth to $27 million with B2B2C gross margins exceeding 80%. Even at Hinge's more conservative expected IPO valuation of $3 billion, the 7.7x revenue multiple would value DRIO at over $207.9 million compared to its current market cap of approximately $28 million – representing a potential upside of 642%. At the higher end of Hinge's expected valuation range ($6 billion or 15.4x revenue), a similar multiple applied to DRIO would yield a valuation of $415.8 million – suggesting a potential 1,485% upside if the valuation gap were to close.

DarioHealth's recent performance further strengthens the investment case. Its Q4 B2B2C recurring revenue surged 398% year-over-year, driven by rapid adoption across employers and health plans. The company has secured multiple Blue Cross Blue Shield agreements, expanded its GLP-1 weight management solution targeting the rapidly growing $100 billion weight-loss market, and integrated an extensive behavioral health provider network, positioning it for accelerated growth in 2025 with 50% projected client expansion.

The comparison highlights a key advantage for DarioHealth: while Hinge offers an MSK-focused solution within the $661 billion musculoskeletal market, DarioHealth's platform addresses multiple chronic conditions including diabetes, hypertension, weight management, MSK, and behavioral health – providing a more comprehensive offering that spans the $1.2 trillion cardiometabolic disease market. This broader approach delivers greater value to healthcare purchasers seeking to consolidate digital health vendors amid rising healthcare costs.

With its AI-driven technology demonstrating significant clinical outcomes, including a proven 5x ROI for payors, DarioHealth's $34.5 million cash position and path to operational cash flow breakeven by year-end create a unique risk-reward profile ahead of potential sector revaluation sparked by Hinge's public debut.

DarioHealth could represent a potential opportunity to participate in the same trends driving Hinge's expected multi-billion valuation at IPO, but at a fraction of the relative value.

>> Subscribe for More Alerts Here

https://newsletter.page/wallstreetalerts

Recent News from Dario:

* Disclaimer: Nothing in this report constitutes financial or investment advice, nor does it represent an offer to buy or sell securities. This report is published by Market News Alerts, a brand which is part of the Wall Street Wire™ network. The operators of Wall Street Wire are not registered brokers, dealers, or investment advisers. This report contains and is a form of paid promotional content related to DarioHealth and was produced as part of their paid subscription to Wall Street Wire. This report has not been reviewed or approved by DarioHealth prior to publication. The information in this above news report include the numbers relating to HingeHealth’s IPO are based on publicly available news reports and filings which have not been independantly verified by us. Please review the full disclaimers and compensation disclosures here: redditwire.com/terms.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.